Logo.png
Ocean Biomedical Announces Loan Commitment from Largest Stockholder; Up to $10 Million
04. Oktober 2023 08:01 ET | Ocean Biomedical, Inc.
Providence, RI, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA) announced today that it has entered into a non-binding term sheet with its largest stockholder, Poseidon Bio,...
Logo.png
Ocean Biomedical, Inc. Enters into a $25 Million Convertible Note Facility
16. Mai 2023 08:01 ET | Ocean Biomedical, Inc.
Providence, RI, May 16, 2023 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company working to accelerate the development and commercialization of scientifically compelling...
logo.jpg
Ocean Biomedical and Aesther Healthcare Acquisition Corp. Announce the Award of New Patents for Novel Monospecific and Bispecific Antibodies that Suppress Multiple Cancer Types
09. Februar 2023 09:15 ET | Aesther Healthcare Acquisition Corp.
Multiple Patents granted for Methods and Composition for Mono-specific and Bi-specific antibody approaches that suppress tumors by targeting and neutralizing elevated levels of chitinase 3-like-1...